Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14471
Articles
Company
Drug
Eli Lilly’s Tirzepatide Shows Robust Weight Loss Results in Phase III Study
November 15, 2024
Company
Drug
Simcere’s SIM0237 Receives NMPA Approval for Bladder Cancer Trial
November 15, 2024
Company
Drug
Abbisko Therapeutics to Unveil Phase I Data for ABSK011 and ABSK043 at ESMO 2023
November 15, 2024
Company
Medical Device
MicroPort CardioFlow Medtech’s Third-Generation TAVI Product Achieves Initial Clinical Success
November 15, 2024
Company
Deals
Suzhou Inhal Pharma Secures Series A Funding for Expansion and Clinical Advances
November 15, 2024
Company
Drug
CANbridge’s Maralixibat Receives Priority Review for PFIC Treatment in China
November 15, 2024
Company
R&D
WuXi Biologics Launches WuXiUI: A Revolutionary Biotech Patent Platform
November 15, 2024
Company
Drug
Fosun Pharma Initiates Phase III Trial for ET-26 Anesthetic in China
November 15, 2024
Company
Drug
Kelun-Biotech to Present SKB264 Study Results for Metastatic Breast Cancer at ESMO
November 15, 2024
Policy / Regulatory
China’s 9th National VBP Round Sets Rules for 42 Drugs Tender
November 15, 2024
Company
Drug
Vcanbio Receives NMPA Approval for Stem Cell Therapy VUM02 Clinical Trial
November 15, 2024
Company
Deals
Nona Biosciences Partners with Ingenia for Immunological Therapeutics Development
November 15, 2024
1
2
…
862
863
864
865
866
…
1,205
1,206
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?